{
"NDC": {
"NDCCode": "68682-582-30",
"PackageDescription": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-582-30) ",
"NDC11Code": "68682-0582-30",
"ProductNDC": "68682-582",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Bupropion Hydrobromide",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Bupropion Hydrobromide",
"DosageFormName": "TABLET, EXTENDED RELEASE",
"RouteName": "ORAL",
"StartMarketingDate": "20260629",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA AUTHORIZED GENERIC",
"ApplicationNumber": "NDA022108",
"LabelerName": "Oceanside Pharmaceuticals",
"SubstanceName": "BUPROPION HYDROBROMIDE",
"StrengthNumber": "522",
"StrengthUnit": "mg/1",
"Pharm_Classes": "Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-06-30",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": null,
"StartMarketingDatePackage": "20260629",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}